{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:07:55Z","timestamp":1788826075958,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.htct.2026.106437","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:31:47Z","timestamp":1773365507000},"page":"106437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry"],"prefix":"10.1016","volume":"48","author":[{"given":"C","family":"Freire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Noboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3928-7896","authenticated-orcid":false,"given":"C","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-2411","authenticated-orcid":false,"given":"H","family":"Chiang-Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8133-8154","authenticated-orcid":false,"given":"M","family":"Buena\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3323-9127","authenticated-orcid":false,"given":"R","family":"Loachamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-761X","authenticated-orcid":false,"given":"F","family":"Huam\u00e1n-Garaicoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106437_bib0001","series-title":"2020 Manual of recommendations on philadelphia-negative chronic myeloproliferative neoplasms","year":"2020"},{"key":"10.1016\/j.htct.2026.106437_bib0002","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.htct.2026.106437_bib0003","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2026.106437_bib0004","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2026.106437_bib0005","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4067\/S0034-98872021001101532","article-title":"Clinical and epidemiological characteristics of Philadelphia-negative myeloproliferative neoplasms in the Chilean public health system","volume":"149","author":"Valladares","year":"2021","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.htct.2026.106437_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4067\/s0034-98872022000700849","article-title":"Study of mutations in Philadelphia-negative myeloproliferative neoplasms in a Chilean public hospital","volume":"150","author":"Jaramillo","year":"2022","journal-title":"Rev Med Chile"},{"issue":"2","key":"10.1016\/j.htct.2026.106437_bib0007","first-page":"66","article-title":"Clinical and paraclinical characteristics of Philadelphia chromosome-negative chronic myeloproliferative neoplasms","volume":"37","author":"Solano","year":"2012","journal-title":"Acta Med Colomb"},{"issue":"1","key":"10.1016\/j.htct.2026.106437_bib0008","first-page":"35","article-title":"Description of clinical characteristics of chronic myeloproliferative neoplasms (MPNs). First report of the Colombian MPN registry","volume":"42","author":"Abello","year":"2017","journal-title":"Acta Med Colomb"},{"issue":"4","key":"10.1016\/j.htct.2026.106437_bib0009","first-page":"73","article-title":"Detection of the JAK2 V617F mutation in Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"33","author":"Cruz Alem\u00e1n","year":"2017","journal-title":"Rev Cub Hematol, Inmunol y Hemoterapia"},{"issue":"276","key":"10.1016\/j.htct.2026.106437_bib0010","article-title":"Characterization of patients with chronic myeloproliferative neoplasms in San Crist\u00f3bal","volume":"59","author":"Areces L\u00f3pez","year":"2020","journal-title":"Rev Cientif Estud Univ Ciencias Med La Habana"},{"issue":"4","key":"10.1016\/j.htct.2026.106437_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1590\/S1516-84842010005000091","article-title":"Myeloproliferative neoplasms: a review of diagnostic criteria and clinical aspects","volume":"32","author":"Chauffaille","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"10.1016\/j.htct.2026.106437_bib0012","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.htct.2023.09.401","article-title":"Real-world data analysis of a cohort of Brazilian patients with chronic myeloproliferative neoplasms","volume":"45","author":"Akkam","year":"2023","journal-title":"Hematol, Transf Cell Ther"},{"issue":"4","key":"10.1016\/j.htct.2026.106437_bib0013","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1016\/j.htct.2024.09.801","article-title":"Epidemiological profile, clinical characteristics, and complications of patients with classical myeloproliferative neoplasms in Brazil","volume":"46","author":"Guaran\u00e1","year":"2024","journal-title":"Hematol, Transf Cell Ther"},{"key":"10.1016\/j.htct.2026.106437_bib0014","series-title":"Undergraduate Thesis","author":"Villanueva Garc\u00eda","year":"2018"},{"key":"10.1016\/j.htct.2026.106437_bib0015","series-title":"Master's Thesis","author":"Girardi","year":"2016"},{"issue":"2","key":"10.1016\/j.htct.2026.106437_bib0016","first-page":"20","article-title":"BCR-ABL negative chronic myeloproliferative neoplasms: clinical manifestation and progression. Experience at the Hospital Italiano of Buenos Aires","volume":"24","author":"Aguilar Vera","year":"2020","journal-title":"Hematolog\u00eda"},{"key":"10.1016\/j.htct.2026.106437_bib0017","series-title":"Specialization Thesis","author":"Acon Solano","year":"2018"},{"key":"10.1016\/j.htct.2026.106437_bib0018","series-title":"Specialization Thesis","author":"Mart\u00ednez Flores","year":"2015"},{"key":"10.1016\/j.htct.2026.106437_bib0019","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41375-022-01773-0","article-title":"Continuous indexing of fibrosis (CIF): improving the assessment and classification of MPN patients","volume":"37","author":"Ryou","year":"2023","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.htct.2026.106437_bib0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3324\/haematol.2015.141283","article-title":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis, and targeted strategies","volume":"101","author":"Zahr","year":"2016","journal-title":"Haematologica"},{"issue":"s1","key":"10.1016\/j.htct.2026.106437_bib0021","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2024-202336","article-title":"Reticulin-free quantitative assessment of bone marrow fibrosis in myeloproliferative neoplasms; time to sell the Family silver?","volume":"144","author":"Ryou","year":"2024","journal-title":"Blood"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:24:12Z","timestamp":1788823452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926001847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2531137926001847"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106437","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106437"}}